In vitro study of factors influencing the duration of antimicrobial protection of antimicrobial-impregnated external ventricular drains.


Journal

The Journal of antimicrobial chemotherapy
ISSN: 1460-2091
Titre abrégé: J Antimicrob Chemother
Pays: England
ID NLM: 7513617

Informations de publication

Date de publication:
23 02 2022
Historique:
received: 08 06 2021
accepted: 29 10 2021
pubmed: 6 12 2021
medline: 5 3 2022
entrez: 5 12 2021
Statut: ppublish

Résumé

In vitro and clinical studies assessing the duration of the protective activity of antimicrobial-impregnated external ventricular drains (AI-EVDs) gave conflicting results. To identify factors associated with decreased antimicrobial activity of AI-EVDs that were not taken into account in previous in vitro models. We performed in vitro experiments with Bactiseal™ AI-EVDs, under different conditions. Tested parameters were chosen to mimic conditions in which AI-EVDs are used: perfusion by saline (at different flow rates) or not perfused, dwelling medium (air, saline, saline+protein, lipid) and temperature. Antimicrobial activity was assessed by measurement of inhibitory diameters of a 0.5 cm portion of an AI-EVD (cut every 2 days) placed onto agar plates covered by a standardized Staphylococcus spp. inoculum (three different isolates). MS was used to measure concentrations of rifampicin and clindamycin after 48 h of dwelling. In univariate analysis, most of the tested factors were associated with reduced antimicrobial activity: liquid media (as compared with ambient air), perfusion whatever the rate flow (as compared with no perfusion) and presence of protein in the media. In multivariate analysis, dwelling in media (lipid or saline) was the most constantly associated with a reduction of inhibition diameters (P < 0.01), as compared with ambient air. After 48 h of dwelling, the clindamycin concentration was higher than 100 and 450 mg/L in saline and saline+BSA, respectively. The medium in which an AI-EVD is dwelling plays a significant role in the duration of AI-EVD activity. These results may explain conflicting results between clinical and in vitro studies.

Sections du résumé

BACKGROUND
In vitro and clinical studies assessing the duration of the protective activity of antimicrobial-impregnated external ventricular drains (AI-EVDs) gave conflicting results.
OBJECTIVES
To identify factors associated with decreased antimicrobial activity of AI-EVDs that were not taken into account in previous in vitro models.
METHODS
We performed in vitro experiments with Bactiseal™ AI-EVDs, under different conditions. Tested parameters were chosen to mimic conditions in which AI-EVDs are used: perfusion by saline (at different flow rates) or not perfused, dwelling medium (air, saline, saline+protein, lipid) and temperature. Antimicrobial activity was assessed by measurement of inhibitory diameters of a 0.5 cm portion of an AI-EVD (cut every 2 days) placed onto agar plates covered by a standardized Staphylococcus spp. inoculum (three different isolates). MS was used to measure concentrations of rifampicin and clindamycin after 48 h of dwelling.
RESULTS
In univariate analysis, most of the tested factors were associated with reduced antimicrobial activity: liquid media (as compared with ambient air), perfusion whatever the rate flow (as compared with no perfusion) and presence of protein in the media. In multivariate analysis, dwelling in media (lipid or saline) was the most constantly associated with a reduction of inhibition diameters (P < 0.01), as compared with ambient air. After 48 h of dwelling, the clindamycin concentration was higher than 100 and 450 mg/L in saline and saline+BSA, respectively.
CONCLUSIONS
The medium in which an AI-EVD is dwelling plays a significant role in the duration of AI-EVD activity. These results may explain conflicting results between clinical and in vitro studies.

Identifiants

pubmed: 34865046
pii: 6448273
doi: 10.1093/jac/dkab436
doi:

Substances chimiques

Anti-Bacterial Agents 0
Anti-Infective Agents 0
Clindamycin 3U02EL437C

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

682-688

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Elodie Lang (E)

Department of Neuro-ICU, GHU-Paris, Paris University, Paris, France.
Université de Paris, 75006 Paris, France.

Anne Hulin (A)

Department of Pharmacology, Henri Mondor University Hospital Assitance Publique-Hôpitaux de Paris (APHP), University Paris-Est-Créteil (UPEC), Paris, France.

Julia Egbeola-Martial (J)

Department of Neuro-ICU, GHU-Paris, Paris University, Paris, France.
Université de Paris, 75006 Paris, France.

Leonard Drouard (L)

Department of Neuro-ICU, GHU-Paris, Paris University, Paris, France.
Université de Paris, 75006 Paris, France.

Ariane Roujansky (A)

Department of Neuro-ICU, GHU-Paris, Paris University, Paris, France.
Université de Paris, 75006 Paris, France.

Françoise Tomberli (F)

Department of Neuro-ICU, GHU-Paris, Paris University, Paris, France.
Université de Paris, 75006 Paris, France.

Jean Bardon (J)

Department of Neuro-ICU, GHU-Paris, Paris University, Paris, France.
Université de Paris, 75006 Paris, France.

Caroline Schimpf (C)

Department of Neuro-ICU, GHU-Paris, Paris University, Paris, France.
Université de Paris, 75006 Paris, France.

Suhan Senova (S)

Department of Neurosurgery, Henri Mondor University Hospital Assitance Publique-Hôpitaux de Paris (APHP), University Paris-Est-Créteil (UPEC), Paris, France.
INSERM U955, Team 15, Institut Mondor de Recherche Biomédicale, University Paris-Est-Créteil (UPEC), Paris, France.

Fabrice Cook (F)

Intensive Care Unit, Cayenne General Hospital, Av des Flamboyants, 97306 Cayenne, French Guiana.

David Lebeaux (D)

Université de Paris, 75006 Paris, France.
Service de Microbiologie, Unité Mobile d'Infectiologie, AP-HP, Hôpital Européen Georges Pompidou, 20 rue Leblanc, 75015 Paris, France.

Roman Mounier (R)

Department of Neuro-ICU, GHU-Paris, Paris University, Paris, France.
Université de Paris, 75006 Paris, France.
INSERM U955, Team 15, Institut Mondor de Recherche Biomédicale, University Paris-Est-Créteil (UPEC), Paris, France.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Humans Arthroplasty, Replacement, Elbow Prosthesis-Related Infections Debridement Anti-Bacterial Agents
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation
Humans Hematoma, Subdural, Chronic Drainage Male Female

Classifications MeSH